The global Mapping Catheters market size was estimated at USD 3.07 billion in 2023 and is projected to reach USD 5.46 billion in 2030 at a CAGR of 8.60% during the forecast period 2023-2030.
Mapping Catheters are thin, flexible tubes that are inserted into the heart through a vein in the leg. They are used to map electrical activity of the heart, which can be used to identify the source of an arrhythmia. Mapping catheters are of two types – contact mapping catheters and non-contact mapping catheters. Contact mapping catheters are the most common type. They have electrodes that touch the heart tissue, which allows them to record the electrical activity of the heart. Non-contact mapping catheters use magnetic fields or ultrasound to record the electrical activity of the heath without touching the heart tissue.
Mapping catheters are used in a variety of procedures such as atrial fibrillation ablation, atrial flutter ablation, ventricular tachycardia ablation, ventricular fibrillation ablation, etc. They are a valuable tool for the diagnosis and treatment of arrhythmias. They allow doctors to see exactly where in the heart the arrhythmia is coming from, which helps them to choose the best treatment.
The increasing prevalence of arrhythmias is one of the key drivers of the global mapping catheters market. The WHO estimated that arrhythmias affect over fifty million people worldwide. The rising demand for minimally invasive procedure is yet another driver of the market. Mapping catheters use minimally invasive procedures, which are less invasive than traditional open-heart surgery.
Moreover, technological advancements in mapping catheters are also driving the growth of the market. New mapping catheters are being developed that are more precise and easier to use. These advancements are making mapping catheters more effective in the diagnosis and treatment of arrhythmias.
The global mapping catheters market is segmented by type, indication, end user and region. By type, the market is segmented into contact mapping systems and non-contact mapping systems. By indication, the market is bifurcated into atrial fibrillation, atrial flutter, and other arrhythmias. By end user, the market is segmented into hospitals, clinics and others. Lastly, based on region the market is divided into North America, Europe, Asia-Pacific, Middle East and Africa and South America.
North America is the largest market for mapping catheters followed by Europe and Asia Pacific. The growth of the market in North America is being driven by high prevalence of arrhythmias and the rising demand for minimally invasive procedures.
COVID-19 pandemic had a positive impact in the market. COVID-19 pandemic had an impact on people's lifestyles, resulting in numerous consequences like hypertension, cholesterol, diabetes, and obesity, which can cause strokes, cardiac arrests, or deadly heart attacks. In addition, excessive alcohol consumption increases the risk of atrial fibrillation. Hence, these factors lead to the increase in the demand for the mapping catheter devices.
COVID-19 pandemic positively impacted the mapping catheter market as changes were seen in the consumer demand and behaviour, buying habits, supply chain redirections and significant government initiatives. Due to lockdown restrictions, changes were seen in nutrition patterns and levels of substance use in individuals which led to increase in cardiovascular abnormalities which drove the growth of the market. In addition to that, increasing prevalence of arrhythmias in recent times, rising demand for minimal invasive procedures and technological advancements are also factors responsible for the growth of the market in the forecast period.
North America to Dominate the Market
